Skip to main content
OpenTrials

Clinical trial condition

Uterine Cervical Diseases

Explore clinical trials studying Uterine Cervical Diseases. Study availability and eligibility vary by location and protocol.

1,753 public trials 368 recruiting studies
Refine in advanced search Browse all conditions

Uterine Cervical Diseases trial results

Active, Not Recruiting

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer

NCT01566240

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Instituto do Câncer do Estado de São Paulo São Paulo, Brazil
  • Chittaranjan National Cancer Institute (CNCI) Kolkata, India
  • Saroj Gupta Cancer Centre and Research Institute Kolkata, India
  • Istituto Europeo di Oncologia Milan, Lombardy, Italy
View all 35 locations
View Trial Details
Active, Not Recruiting

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

NCT04723875

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Tongji Hospital Wuhan, Hubei, China
  • Qilu Hospital, Shandong University, 107 West Wenhua Road Ji'nan, Shandong, China
  • Women's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details

Related conditions